Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients

Christoph Ausch(Ludwig Boltzmann Institute for Cardiovascular Research), G. Hamilton(Ludwig Boltzmann Institute for Cardiovascular Research), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Ulrike Olszewski(Ludwig Boltzmann Institute for Cardiovascular Research), E Ogris(Ludwig Boltzmann Institute for Cardiovascular Research), W Hinterberger(Ludwig Boltzmann Institute for Cardiovascular Research), R Schiessel(Ludwig Boltzmann Institute for Cardiovascular Research)
European Journal of Surgical Oncology
March 2, 2009
10.1016/j.ejso.2009.02.007
Cited by 49

Related Papers

Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)
|Blood|2012|596
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
|Blood|2011|448
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
|The Lancet Haematology|2020|351
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia
|Blood Cancer Journal|2015|273